Status:
COMPLETED
Clinical Trials of Two Helichrysum Infusions in Adults
Lead Sponsor:
University of Primorska
Conditions:
Hypertension
Hyperlipidemias
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
The study evaluates the effects of Helichrysum italicum and Helichrysum Arenarium on different components of the metabolic syndrome. The components of metabolic syndrome will be measured at baseline a...
Detailed Description
Helichrysum arenarium (HA) has a long tradition in European ethno-medicine as a medicinal plant with many known activities; EU monograph supports its use for the digestive disorders, feeling of fullne...
Eligibility Criteria
Inclusion
- stable weight in the last 3 months
- BMI more than 25
- clinical diagnosis of at least two components of metabolic syndrome,
Exclusion
- consumption of dietary supplements
- medications for any component of metabolic syndrome
Key Trial Info
Start Date :
May 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 19 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04866628
Start Date
May 6 2021
End Date
June 19 2021
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Primorska, Faculty of Health Sciences
Izola, Slovenia, 6310